Frankfurt - Delayed Quote EUR

Vaxcyte, Inc. (5VA.F)

Compare
69.50
-1.00
(-1.42%)
At close: March 3 at 8:08:39 AM GMT+1
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
569,546
569,546
393,041
209,261
102,085
Operating Income
-569,546
-569,546
-393,041
-209,261
-102,085
Net Non Operating Interest Income Expense
109,994
109,994
62,907
8,354
337
Other Income Expense
-4,375
-4,375
-72,132
-22,578
1,671
Pretax Income
-463,927
-463,927
-402,266
-223,485
-100,077
Net Income Common Stockholders
-463,927
-463,927
-402,266
-223,485
-100,077
Diluted NI Available to Com Stockholders
-463,927
-463,927
-402,266
-223,485
-100,077
Basic EPS
-4.60
-3.80
-4.14
-3.44
-1.93
Diluted EPS
-4.60
-3.80
-4.14
-3.44
-1.93
Basic Average Shares
113,829.20
121,997.35
97,157.69
64,877.99
51,922.11
Diluted Average Shares
113,829.20
121,997.35
97,157.69
64,877.99
51,922.11
Total Operating Income as Reported
-569,546
-569,546
-468,041
-232,256
-103,670
Total Expenses
569,546
569,546
393,041
209,261
102,085
Net Income from Continuing & Discontinued Operation
-463,927
-463,927
-402,266
-223,485
-100,077
Normalized Income
-463,927
-463,927
-327,266
-200,490
-101,748
Interest Income
109,994
109,994
62,907
8,356
344
Interest Expense
--
--
--
2
7
Net Interest Income
109,994
109,994
62,907
8,354
337
EBIT
-463,927
-463,927
-402,266
-223,483
-100,070
EBITDA
-448,082
-448,082
-392,095
-214,030
-96,613
Reconciled Depreciation
15,845
15,845
10,171
9,453
3,457
Net Income from Continuing Operation Net Minority Interest
-463,927
-463,927
-402,266
-223,485
-100,077
Total Unusual Items Excluding Goodwill
--
--
-75,000
-22,995
1,671
Total Unusual Items
--
--
-75,000
-22,995
1,671
Normalized EBITDA
-448,082
-448,082
-317,095
-191,035
-98,284
12/31/2021 - 9/22/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers